SMARCA1 and digestive system neoplasm: A panel of endometrium, lung, ovary and gastrointestinal tumor cell lines with SWI/SNF LOF mutations (Supplementary Table S1) were selected, and the expression levels of the SWI/SNF subunits were analyzed by western blotting (Fig. 1B).